Family Bank: ReeLabs

About

Founded in 2009 by two MD Pathologists and an IIT graduate, ReeLabs Pvt. Ltd. was established with a singular vision to position India as a global leader in stem cell storage, research and treatment. ReeLabs has become India's first integrated stem cell company, with services that cross the spectrum from biobanking to delivery of therapies.

In its continued commitment to stem cell research, ReeLabs has set up India's largest, state of the art stem cell facility in the heart of Mumbai. Our facility features a Class 100,000 lab premise, a Class 10,000 clean room and a Class 100 safety workbench for stem cell harvesting, ensuring the highest standards of precision and safety. We are proudly FDA, GLP (Good Laboratory Practices) and GMP (Good Manufacturing Practices) approved.

ReeLabs is also the only company in India that has the capability and technology to bank stem cells from the Placenta (Chorion), Amniotic Sac and Amniotic Fluid. We are the only one that provides a certificate of analysis for these cells.

Labs and Locations

Laboratory: ReeLabs (self-owned, processing and storage)
169, Royal Palms Estate, Aarey Colony,
Goregaon (East), Mumbai – 400065
Maharashtra, India

Video tour of our lab: https://www.youtube.com/watch?v=tESaZoZqiO0

Business Experience

ReeLabs, founded in 2009, has India’s largest stem cell facility, situated in Mumbai. By the end of 2025, the inventory of the bank was over 100,000.

ReeLabs holds: 13 Patents, 7 Clinical Trials, 20 Proprietary Inventions, 300+ International Publications

Proprietary Technologies:

1. India’s first and the only cord blood bank with technological capabilities to commercially processes and bank stem cells from ten human sources: cord blood, cord tissue, placenta, amniotic sac, amniotic fluid, bone marrow, dental samples, adipose tissue and menstrual blood.
2. Mesenchymal Stromal Cell (MSC) isolation, culture, characterization and expansion from a combination of three perinatal sources: Amniotic Sac, Chorion, and Umbilical Cord tissue (Wharton's Jelly).
3. Stem cell application in chronic wounds and burns.
4. Ex-Vivo expansion of CD34+ hematopoietic stem cells.
5. Ex-vivo expansion of NK cells from cord blood for immunotherapy.
6. Plasma enriched with exosomes derived from cord blood for anti-aging applications.
7. Human placenta-based stem cell creams for anti-aging of face, neck, and body.
8. Human placenta-based stem cell serums to reverse hair loss and alopecia.
9. Experimental influence of placenta in treatment of cancers.
10. Chimeric antigen receptor (CAR) T-cell immunotherapy as a cancer treatment using the patient's own T-lymphocytes to fight cancer cells.
11. Diagnostic Protein Specific autologous peripheral blood therapy to treat cancers (solid tumours).
12. Convalescent plasma-based treatment against COVID-19.
13. Human placenta-based stem cell treatment against COVID-19.
14. Autologous in-vitro 3-D Hair follicle multiplication to address hair-loss and baldness.
15. Autologous Melanocyte culture to overcome hypo-pigmentation or vitiligo patches.
16. Fetal progenitor cell isolation and expansion technology.
17. Golden Vial® Program for documented reversal of biological age.
18. Niche herbal and nutraceuticals products (ReeLabs Wellness).
19. Production of Biodegradable capsules containing millions of islets of Langerhans’s derived from stem cells to reverse Type 1 Diabetes Mellites.
20. Lyophilization of cell based products from their liquid form to powder form for convenient transfer, especially to distant sites of transfusion.
21. All Purpose Organic Coconut Balm.

Collection Kit

ReeLabs Cord Blood Collection Kit can be used in the operating room during a C-section or normal delivery and consists of a blood bag, four gel packs, two sterile collection jars, an EDTA vacutainer, a plain vacutainer with gel, a set of sterile gloves, saline, an alcohol swab, a bandage, a syringe, a vacutainer needle, a vacutainer holder, a tourniquet, and Gentamicin.

ReeLabs Placental Collection Kit can be used in the operating room during a C-section or normal delivery and consists of four gel packs, one sterile collection jar with bag, an EDTA vacutainer, a plain vacutainer with gel, a set of sterile gloves, saline, an alcohol swab, a bandage, a syringe, a vacutainer needle, a vacutainer holder, a tourniquet, and Gentamicin.

Transportation container

ReeLabs collection kit is specially designed as a robust, insulated container to ensure the integrity and safety of the biological material during transportation. It acts as a controlled environment, and its temperature stability is critically maintained by the inclusion of four specialized Gel packs. These packs work to keep the internal temperature of the kit within the narrow range required to preserve the viability and quality of the stem cells until the kit is promptly delivered to the laboratory for processing.

Shipping Info

ReeLabs partners with professional medical courier services to manage the critical transportation of the collected biological samples. The service ensures that once the sample is collected at the birthing center, a courier is immediately dispatched to pick up the specialized collection kit and deliver it to the ReeLabs processing facility. We strive ensure the fastest possible delivery to the lab, which is vital for preserving the viability and potency of the stem cells. Our laboratory is operational 24/7 which minimizes the time between collection and processing, a key factor in maximizing the quality of the stored cells. This service is included in the base price in India. International shipment will incur additional costs.

Processing Method

ReeLabs offers two options for cord blood processing: HES and TotiCyte

Cord Blood Processing using HES Method (Hydroxyethyl Starch Sedimentation):
This process involves adding the polymer Hydroxyethyl Starch (HES) to the collected cord blood. HES acts to increase the sedimentation rate of the heavier, less desirable Red Blood Cells (RBCs), causing them to rapidly clump together and settle at the bottom of the container due to gravity. The remaining fluid, which is rich in lighter components including plasma and the valuable stem cells, forms an upper layer called the buffy coat. This stem cell-rich layer is then carefully extracted, concentrated, and prepared for cryopreservation, while the majority of the settled RBCs are discarded.

Cord Blood Processing using Toticyte Method:
The TotiCyte method is an advanced, proprietary processing technique designed for high efficiency in stem cell recovery. This method uses a specialized solution, incorporating components like Dextran and DMSO, which is mixed with the cord blood sample. Similar to HES, this mixture causes the Red Blood Cells (RBCs) to quickly settle to the bottom using gravity, but the TotiCyte solution is specifically engineered to achieve an exceptionally high level of RBC depletion (often over 99%). Crucially, this method is optimized to ensure a high recovery rate of the viable stem cells, including rare and early progenitor cells, which can potentially lead to a higher-quality final product for future therapeutic applications.

Placental Stem Cell Processing
Processing the placenta involves isolating Mesenchymal Stem Cells (MSCs) from the solid placental tissue after the birth and cord blood collection are complete. This method differs significantly from liquid cord blood processing as it requires breaking down solid material. First, the placental tissue is thoroughly cleaned to remove any residual blood. It is then meticulously cut into small pieces to increase the surface area. Finally, enzymatic digestion is used to chemically digest and loosen the cellular connections, effectively releasing the valuable Placental Mesenchymal Stromal Cells (PMSCs) from the surrounding tissue matrix. These isolated cells are then purified, typically expanded in a lab culture to increase their quantity, and ultimately prepared for long-term cryopreservation.

Components Stored

ReeLabs provided a Certificate of Analysis (COA) which contains the following information:

• Cord Blood Group
• Total Nucleated Cell Count (TNC)
• Mononucleated Cell Count (MNC)
• CD34+ Cell Count
• CD34+ Cell Viability
• Umbilical Cord Tissue Cell Count
• Amniotic Fluid (exclusive to ReeLabs)
• Amniotic Sac Cell Count (exclusive to ReeLabs)
• Chorion Cell Count (exclusive to ReeLabs)

Storage Method

Stem cells are cryopreserved at -196°C / -320.8°F in multiple vials to avoid wastage, allowing multiple use, across multiple medical indications.

Licensing & Accreditation

• DCGI (Drug Control General of India)
• DSIR (Department of Scientific and Industrial Research) licensed for R&D
• ICMR (Indian Council of Medial Research)
• CTRI (Clinical Trials Registry- India)
• FDA (Food and Drug Administration)
• GMP (Good Manufacturing Practice)
• GLP (Good Laboratory Practice)
• CDSCO (Central Drugs Standard Control Organisation)
• WHO GMP for Blood Establishment
• ISO 9001:2008 (International Standards Organisation)
• ISRS (Indian Society of Regenerative Science)

Clinical Experience

ReeLabs has a distinguished list of doctors, researchers, philanthropists and entrepreneurs diligently involved in clinically relevant R&D with respect to regenerative medicine and biobanking. ReeLabs has spearheaded regulator-approved clinical trials (3), authored medical publications (over 300), authored chapters in significant reference textbooks for postgraduate students of medicine (2), claimed proprietary technologies (20), filed international patents (13), approved therapies in Regenerative Medicine (over 15000) and technology transfer services to listed enterprises overseas (2).

KEY CLINICAL APPLICATIONS AND TRIALS IN REGENERATIVE MEDICINE:

1. Approved clinical trial to treat COVID-19 using a patented MSC product derived from Human Placenta. Clinical Trials Registry of India CTRI/2020/08/027043.
2. Approved clinical trial to treat COVID-19 using Convalescent Plasma. Clinical Trials Registry of India CTRI/2020/05/025299.
3. Approved clinical trial to treat Critical Limb Ischemia (CLI) and Diabetic Foot Ulcer (DFU) using a patented progenitor cell product. Clinical Trials Registry of India  CTRI/2023/05/052776.
4. Acute Intravenous Toxicity Study Of Allogenic Mesenchymal Stem Cells In Swiss Albino Mice: Study No. 121101/RE/PC. 
5. 28 Day Repeated Dose Intravenous Toxicity Study Of Allogenic Mesenchymal Stem Cells In Swiss Albino Mice: Study No. 121102/RE/PC. 
6. Bacterial Reverse Mutation Test Of Allogenic Mesenchymal Stem Cell Derived From Human Placenta And Umbilical Cord Using Salmonella Typhimurium: Study No. 121103/RE/PC. 
7. In Vitro Mammalia Micronucleus Test Of Allogenic Mesenchymal Stem Cell Derived From Human Placenta And Umbilical Cord In Human Lymphocytes: Study No. 121104/RE/PC. 
8. Mammalian In Vivo Erythrocyte Micronucleus Test Of Allogenic Mesenchymal Stem Cell Derived From Human Placenta And Umbilical Cord In Swiss Albino Mice: Study No. 121105/ RE/PC. 
9. Treated 634 patients with Chronic Limb Ischemia in Ukraine and East Europe as part of a FDA approved clinical trial.
10. Treated 500 cases with Liver Cirrhosis in Ukraine and East Europe as part of FDA approved clinical trial.
11. Treated 400 patients with Chronic Obstructive Pulmonary Disease (Smoker's lung) in Ukraine and parts of East Europe as part of a FDA approved clinical trial.
12. Treated over 15000 cases across various indications in regenerative, aesthetic, and cosmetic medicine using autologous minimally manipulated cells and exosomes.

Insurance

• Assistance Worth ₹40,00,000 INR for stem cell transplant for the child or immediate family member.
• Quality Warranty Worth ₹20,00,000 INR if the viability does not meet benchmarked criteria, or if ReeLabs is unable to find a unit of suitable HLA match.
• Full Refund Of Processing And Storage Fees if the stem cells are required for therapeutic use within 24 months of banking.
• Free Global Shipping of the specimen if required by the child or immediate family member.
• Free H.L.A. Testing if the specimen is required for any approved stem cell transplant.
• Free Storage of the child’s stem cells in the unfortunate situation of permanent disability or demise of the sole earning member of the family.
• Disaster Relief Worth ₹20,00,000 INR if the specimen had been impaired or destroyed due to unforeseen circumstances.
• Free Cord Blood (CD34) Expansion technology provided to the client.

Community Service

• Adopted 100 children with Thalassemia Major and pledged to provide them with free essential and lifesaving blood support and medications through their lifespan.
• Provided over 25,000 units (gratis) of blood and blood components as life saver to impoverished patients.
• Provided essential stem cell solutions (gratis) to over 500 ailing patients.

Prices

2025 Prices start at ₹65,00,000 INR inclusive of processing and storage for up to 21 years and ₹85,00,000 INR inclusive of processing and storage for up to 75 years.

Payment plans with easy EMI available upon request.

Additional Services

Free WhatsApp Support Group for Expecting Parents: The group contains CAPPA certified coaches to help expecting parents navigate through their pregnancy. Parents will not only have access to daily tips on nutrition, exercise, parenting advise but also a safe space to ask any doubts, big or small. This group is open to all expecting parents, even if they do not choose to bank with ReeLabs.

Free WhatsApp Support Group for New Parents: For new parents with infants from 0 - 12 months, guided by CAPPA certified Coaches. This group will help new parents navigate the initial few months and provide information on baby care / nutrition for baby and mom / breastfeeding support / gentle sleep support and many more such relevant topics.